Current Options and Future Directions in Immune Therapy for Glioblastoma
Author:
Publisher
Frontiers Media SA
Subject
Cancer Research,Oncology
Reference297 articles.
1. Antibody-based immunotherapy for malignant glioma;Gedeon;Seminars Oncol.,2014
2. Bevacizumab plus Radiotherapy–Temozolomide for newly diagnosed glioblastoma;Chinot;N Engl J Med.,2014
3. CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008-2012;Ostrom;Neuro Oncol.,2015
4. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma;Stupp;N Engl J Med,2005
5. Gliadel wafer implantation combined with standard radiotherapy and concurrent followed by adjuvant temozolomide for treatment of newly diagnosed high-grade glioma: a systematic literature review;Ashby;World J Surg Oncol.,2016
Cited by 21 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A Synopsis of Biomarkers in Glioblastoma: Past and Present;Current Issues in Molecular Biology;2024-07-03
2. Immunotherapeutic Strategies for the Treatment of Glioblastoma: Current Challenges and Future Perspectives;Cancers;2024-03-25
3. Insights into the glioblastoma tumor microenvironment: current and emerging therapeutic approaches;Frontiers in Pharmacology;2024-03-08
4. Myeloidcells in the immunosuppressive microenvironment in glioblastoma: The characteristics and therapeutic strategies;Frontiers in Immunology;2023-02-27
5. Dendritic cell vaccines improve the glioma microenvironment: Influence, challenges, and future directions;Cancer Medicine;2022-12-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3